Marina Konopleva, MD, PhD, Albert Einstein College of Medicine, New York, NY, discusses management strategies for tumor lysis syndrome (TLS) in patients with acute myeloid leukemia (AML) treated with venetoclax-based regimens. This interview took place at the 28th Congress of the European Hematology Association (EHA) 2023 in Frankfurt, Germany.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.

свернуть